← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$224K

Shares

7,500

Price

$30

Filed

Jun 18

Insider

Name

Murdock Hunter R.

Title

General Counsel

CIK

0001934008

Roles

Officer

Transaction Details

Transaction Date

2025-06-16

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

7,500

Footnotes

Such transaction was pursuant to a pre-approved 10b5-1 plan. | Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $101.01 and $104.09 | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.53. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.96.

Filing Info

Accession No.

0000950170-25-088105

Form Type

4

Issuer CIK

0001579428

Murdock Hunter R.'s History

Date Ticker Type Value
2026-04-21 AXSM A $0
2026-02-26 AXSM A $0
2025-06-23 AXSM M $180K
2025-06-23 AXSM $602K
2025-06-23 AXSM M $0
2025-06-20 AXSM M $224K
2025-06-20 AXSM $769K
2025-06-20 AXSM M $0
2025-06-18 AXSM M $224K
2025-06-18 AXSM $757K

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
$1.4M 2026-04-22